.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the New York market, Chime & Chill has shown a consistent performance in the Tincture & Sublingual category, maintaining a steady 12th rank from July to October 2025. This stability is noteworthy, especially considering the increase in sales from $12,336 in July to $14,035 in October, indicating a positive growth trend despite maintaining the same rank. However, in the Topical category, Chime & Chill made a brief appearance in the rankings in August, securing the 4th position, but did not sustain this presence in subsequent months, which could suggest a temporary surge or a competitive market landscape.
The absence of Chime & Chill from the Topical category rankings in July, September, and October in New York highlights a potential area for growth or a challenge in maintaining market presence. This fluctuation might point to either a strategic shift in focus or competitive pressures from other brands. The brand's ability to hold its ground in the Tincture & Sublingual category while experiencing volatility in the Topical segment provides a nuanced view of its market dynamics, suggesting areas where Chime & Chill might focus its efforts for improvement or further market penetration.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Chime & Chill has consistently held the 12th rank from July to October 2025. Despite maintaining this position, the brand has shown a positive trend in sales, with a notable increase from September to October 2025. This upward sales trajectory indicates potential for future growth, even though it has not yet translated into an improved rank. In contrast, Jumbodose experienced a decline in both rank and sales over the same period, dropping from 9th to 11th place, which could suggest vulnerabilities that Chime & Chill might capitalize on. Meanwhile, Harney Brothers Cannabis has maintained a stable rank around the 10th position, with relatively steady sales figures. This stability presents a benchmark for Chime & Chill as it seeks to climb the ranks. The competitive dynamics in this market highlight the importance of strategic positioning and the potential for Chime & Chill to leverage its sales growth into improved market standing.
Notable Products
In October 2025, Chime & Chill's top-performing product was the K.O. - CBD Double Dose Tincture (4500mg CBD, 30ml), maintaining its first-place ranking for four consecutive months with a notable sales figure of 241 units. The CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) consistently held the second spot, showing steady performance. The K.O- CBD The Money Melon Distillate Disposable (1g) improved its ranking to third place after fluctuating in previous months, with a significant rise in sales. The CBD/CBG 2:1 AM Body Cream (300mg CBD, 150mg CBG) remained in fourth place, despite a decrease in sales from September. A new entrant, the CBD/CBN/CBG/THC 1:1:1:2 Tigers Blood Live Resin Gummies 10-Pack, debuted at fifth place, marking its entry into the top ranks.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
